Zacks Investment Research upgraded shares of Ageas SA (NASDAQ:AGESY) from a hold rating to a buy rating in a research note published on Friday morning. They currently have $52.00 target price on the stock.

According to Zacks, “Ageas, formerly known as Fortis, is an international insurance company. The Company has chosen to concentrate its business activities in Europe and Asia. Ageas offers international insurance services such as life and non-life, disability, and medical to individuals and groups. The Company also has subsidiaries in France, Germany, Turkey, Ukraine and Hong Kong. Ageas operates partnerships in Luxembourg, Italy, Portugal, China, Malaysia, India and Thailand. “

Ageas SA (NASDAQ:AGESY) opened at 46.70 on Friday. Ageas SA has a 52-week low of $34.65 and a 52-week high of $47.39. The stock has a market capitalization of $9.41 billion and a PE ratio of 21.21. The stock’s 50 day moving average price is $46.32 and its 200-day moving average price is $42.13.

COPYRIGHT VIOLATION NOTICE: This report was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another site, it was illegally copied and reposted in violation of United States & international copyright & trademark legislation. The correct version of this report can be read at https://www.thecerbatgem.com/2017/09/19/ageas-sa-agesy-lifted-to-buy-at-zacks-investment-research.html.

Ageas SA Company Profile

ageas SA is an international insurance company. The Company’s business segments include Belgium, the United Kingdom, Continental Europe, Asia and General Account. The Belgian insurance activities operate under the name of AG Insurance. The Company’s business in the United Kingdom is a national provider of Nonlife insurance solutions.

Get a free copy of the Zacks research report on Ageas SA (AGESY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for Ageas SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ageas SA and related stocks with our FREE daily email newsletter.